LD
Leland Damron
Internal Medicine Residency · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: ·
History
Research
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life
Scientific Reports · 2022 · 16 citations
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
mAbs · 2023 · 15 citations
Cureus · 2024 · 1 citations

4 papers

3 papers · 3 as a fellow
- JM
2 papers
- SH
2 papers

1 paper

1 paper
- AN
1 paper · 1 as a resident

1 paper · 1 as a resident


